1. Home
  2. XBIT vs TTEC Comparison

XBIT vs TTEC Comparison

Compare XBIT & TTEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo XBiotech Inc.

XBIT

XBiotech Inc.

N/A

Current Price

$1.88

Market Cap

69.8M

Sector

Health Care

ML Signal

N/A

Logo TTEC Holdings Inc.

TTEC

TTEC Holdings Inc.

N/A

Current Price

$1.39

Market Cap

67.0M

Sector

Technology

ML Signal

N/A

Company Overview

Basic Information
Metric
XBIT
TTEC
Founded
2005
1982
Country
United States
United States
Employees
N/A
69400
Industry
Pharmaceuticals and Biotechnology
Retail: Computer Software & Peripheral Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
69.8M
67.0M
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
XBIT
TTEC
Price
$1.88
$1.39
Analyst Decision
Buy
Analyst Count
0
3
Target Price
N/A
★ $4.00
AVG Volume (30 Days)
92.8K
★ 347.8K
Earning Date
11-20-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 40.80
EPS
N/A
★ N/A
Revenue
N/A
★ $1,509,171,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$30.47
$0.71
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 2.15
52 Week Low
$1.80
$1.18
52 Week High
$3.44
$3.99

Technical Indicators

Market Signals
Indicator
XBIT
TTEC
Relative Strength Index (RSI) 39.12 41.77
Support Level $1.80 $1.19
Resistance Level $2.42 $1.50
Average True Range (ATR) 0.12 0.11
MACD -0.00 -0.02
Stochastic Oscillator 27.27 6.56

Price Performance

Historical Comparison
XBIT
TTEC

About XBIT XBiotech Inc.

XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.

About TTEC TTEC Holdings Inc.

TTEC Holdings Inc provides customer engagement management tools and services. The company operates through two operating segment, TTEC Digital and TTEC Engage. TTEC Digital is engaged in building and implementing cloud-based and on-premises customer experience tools that enable clients to develop customer engagement strategies. TTEC Engage focuses on delivering sales and marketing solutions to help clients boost their revenue as well as on managing customer's front-to-back office processes to optimize the customer experience. TTEC Engage contributes the vast majority of the company's revenue, and its revenues are derived from the United States and Canada, followed by Philippines, Asia-Pacific and India.

Share on Social Networks: